{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:00:48Z","timestamp":1784714448605,"version":"3.55.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00066-026-02545-w","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:36:43Z","timestamp":1779446203000},"page":"809-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perirectal spacers and endorectal balloons in external beam radiotherapy for prostate cancer: a\u00a0review of prospective studies"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-8866","authenticated-orcid":false,"given":"Matthias","family":"Moll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Goldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant","family":"Sushant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"L\u00fctgendorf-Caucig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Hug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"2545_CR1","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","volume":"24","author":"STH Peeters","year":"2006","unstructured":"Peeters\u00a0STH et\u00a0al (2006) Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase\u00a0III trial comparing 68\u202fGy of radiotherapy with 78\u202fGy. J\u00a0Clin Oncol 24:1990\u20131996","journal-title":"J. Clin. Oncol"},{"key":"2545_CR2","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy\u00a0FC et\u00a0al (2023) Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 388:1547\u20131558","journal-title":"N. Engl. J. Med"},{"key":"2545_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ijrobp.2005.10.002","volume":"64","author":"STH Peeters","year":"2006","unstructured":"Peeters\u00a0STH et\u00a0al (2006) Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64:1151\u20131161","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","volume":"98","author":"S Rodda","year":"2017","unstructured":"Rodda\u00a0S et\u00a0al (2017) ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 98:286\u2013295","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijrobp.2022.11.005","volume":"115","author":"J Oh","year":"2022","unstructured":"Oh\u00a0J et\u00a0al (2022) An Updated Analysis of the Survival Endpoints of ASCENDE-RT. Int J Radiat Oncol Biol Phys 115:1061\u20131070","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR6","doi-asserted-by":"crossref","unstructured":"Miszczyk, M. et\u00a0al. Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients. Radiother. Oncol. 183, (2023).","DOI":"10.1016\/j.radonc.2023.109632"},{"key":"2545_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.eururo.2024.08.030","volume":"86","author":"N van As","year":"2024","unstructured":"van As\u00a0N et\u00a0al (2024) Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE\u2011A Randomised Trial. Eur Urol 86:566\u2013576","journal-title":"Eur Urol"},{"key":"2545_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0360-3016(01)01821-1","volume":"52","author":"S Wachter","year":"2002","unstructured":"Wachter\u00a0S et\u00a0al (2002) The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 52:91\u2013100","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","volume":"92","author":"N Mariados","year":"2015","unstructured":"Mariados\u00a0N et\u00a0al (2015) Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 92:971\u2013977","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00066-005-1443-2","volume":"181","author":"A Hille","year":"2005","unstructured":"Hille\u00a0A et\u00a0al (2005) The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer: A prospective three-dimensional analysis. Strahlentherapie und Onkol 181:709\u2013716","journal-title":"Strahlentherapie und Onkol"},{"key":"2545_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.radonc.2017.04.014","volume":"123","author":"T Streller","year":"2017","unstructured":"Streller\u00a0T et\u00a0al (2017) The effect of endorectal balloon on anorectal dose during postoperative volumetric arc radiotherapy of prostate cancer. Radiother Oncol 123:454\u2013458","journal-title":"Radiother Oncol"},{"key":"2545_CR12","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.ijrobp.2010.08.052","volume":"81","author":"S Both","year":"2011","unstructured":"Both\u00a0S et\u00a0al (2011) Real-time study of prostate intrafraction motion during external beam radiotherapy with daily endorectal balloon. Int J Radiat Oncol Biol Phys 81:1302\u20131309","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3109\/0284186X.2016.1161826","volume":"55","author":"S Swisher-McClure","year":"2016","unstructured":"Swisher-McClure\u00a0S et\u00a0al (2016) Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation. Acta Oncol (Madr) 55:828\u2013833","journal-title":"Acta Oncol. (Madr)"},{"key":"2545_CR14","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.ijrobp.2024.07.2145","volume":"120","author":"D Song","year":"2024","unstructured":"Song\u00a0D et\u00a0al (2024) Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy. Int J Radiat Oncol Biol Phys 120:1410\u20131420","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamaoncol.2022.7592","volume":"9","author":"NF Mariados","year":"2023","unstructured":"Mariados\u00a0NF et\u00a0al (2023) Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial. JAMA Oncol 9:511\u2013518","journal-title":"JAMA Oncol"},{"key":"2545_CR16","unstructured":"Spratt DE MD, PhD, Srinivas S, Schaeffer EM, Adra N, Wong JK (2025) Prostate Cancer Prostate Cancer Version 2.2025. NCCN Guidel. Prostate Cancer."},{"key":"2545_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26633\/RPSP.2022.112","volume":"46","author":"MJ Page","year":"2022","unstructured":"Page\u00a0MJ et\u00a0al (2022) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Panam Salud Publica\/Pan Am J Public Heal 46:1\u201311","journal-title":"Rev. Panam. Salud Publica\/Pan Am. J. Public Heal"},{"key":"2545_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim\u00a0K et\u00a0al (2003) Methodological index for non-randomized studies MINORS development and validation. ANZ J Surg 73:712\u2013716","journal-title":"ANZ J Surg"},{"key":"2545_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins\u00a0JPT et\u00a0al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:1\u20139","journal-title":"BMJ"},{"key":"2545_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00066-006-1581-1","volume":"182","author":"M El-Bassiouni","year":"2006","unstructured":"El-Bassiouni\u00a0M et\u00a0al (2006) Target motion variability and on-line positioning accuracy during external-beam radiation therapy of prostate cancer with an endorectal balloon device. Strahlentherapie und Onkol 182:531\u2013536","journal-title":"Strahlentherapie und Onkol"},{"key":"2545_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ijrobp.2006.09.034","volume":"67","author":"ENJT van Lin","year":"2007","unstructured":"van Lin\u00a0ENJT et\u00a0al (2007) Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys 67:799\u2013811","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.radonc.2005.10.009","volume":"78","author":"G Goldner","year":"2006","unstructured":"Goldner\u00a0G et\u00a0al (2006) 3\u2011D conformal radiotherapy of localized prostate cancer: A subgroup analysis of rectoscopic findings prior to radiotherapy and acute\/late rectal side effects. Radiother Oncol 78:36\u201340","journal-title":"Radiother Oncol"},{"key":"2545_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.urology.2005.10.008","volume":"67","author":"AV D\u2019Amico","year":"2006","unstructured":"D\u2019Amico\u00a0AV et\u00a0al (2006) A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization. Urology 67:780\u2013784","journal-title":"Urology"},{"key":"2545_CR24","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ijrobp.2008.06.1491","volume":"73","author":"SWTPJ Heijmink","year":"2009","unstructured":"Heijmink\u00a0SWTPJ et\u00a0al (2009) Changes in Prostate Shape and Volume and Their Implications for Radiotherapy After Introduction of Endorectal Balloon as Determined by MRI at 3T. Int J Radiat Oncol Biol Phys 73:1446\u20131453","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2545_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10147-010-0129-7","volume":"16","author":"K Takayama","year":"2011","unstructured":"Takayama\u00a0K, Mizowaki\u00a0T, Negoro\u00a0Y, Norihisa\u00a0Y, Hiraoka\u00a0M (2011) Impact of double-balloon rectal catheter use in external-beam radiotherapy for prostate cancer. Int J Clin Oncol 16:50\u201356","journal-title":"Int J Clin Oncol"},{"key":"2545_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.radonc.2013.08.024","volume":"109","author":"MG Jameson","year":"2013","unstructured":"Jameson\u00a0MG et\u00a0al (2013) Endorectal balloons in the post prostatectomy setting: Do gains in stability lead to more predictable dosimetry? Radiother Oncol 109:493\u2013497","journal-title":"Radiother Oncol"},{"key":"2545_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2014.05.008","volume":"112","author":"KKH Wang","year":"2014","unstructured":"Wang\u00a0KKH et\u00a0al (2014) The impact of stool and gas volume on intrafraction prostate motion in patients undergoing radiotherapy with daily endorectal balloon. Radiother Oncol 112:89\u201394","journal-title":"Radiother Oncol"},{"key":"2545_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijrobp.2015.12.366","volume":"95","author":"M Moteabbed","year":"2016","unstructured":"Moteabbed\u00a0M et\u00a0al (2016) A prospective comparison of the effects of interfractional variations on proton therapy and IMRT for prostate cancer. Int J Radiat Oncol 95:444\u2013453","journal-title":"Int J Radiat Oncol"},{"key":"2545_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-018-1059-1","volume":"13","author":"A Dubouloz","year":"2018","unstructured":"Dubouloz\u00a0A et\u00a0al (2018) Urethra-sparing stereotactic body radiotherapy for prostate cancer: How much can the rectal wall dose be reduced with or without an endorectal balloon? Radiat Oncol 13:1\u20138","journal-title":"Radiat. Oncol"},{"key":"2545_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.radonc.2018.03.032","volume":"128","author":"R Krol","year":"2018","unstructured":"Krol\u00a0R, McColl\u00a0GM, Hopman\u00a0WPM, Smeenk\u00a0RJ (2018) Anal and rectal function after intensity-modulated prostate radiotherapy with endorectal balloon. Radiother Oncol 128:364\u2013368","journal-title":"Radiother. Oncol"},{"key":"2545_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00508-006-0588-z","volume":"118","author":"G Goldner","year":"2006","unstructured":"Goldner\u00a0G et\u00a0al (2006) 3\u2011D conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: A prospective study of patients\u2019 acceptance of the rectal balloon during treatment. Wien Klin Wochenschr 118:224\u2013229","journal-title":"Wien Klin Wochenschr"},{"key":"2545_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.radonc.2013.01.007","volume":"106","author":"C Melchert","year":"2013","unstructured":"Melchert\u00a0C et\u00a0al (2013) Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: Results of a\u00a0virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study. Radiother Oncol 106:210\u2013214","journal-title":"Radiother Oncol"},{"key":"2545_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-8-96","volume":"8","author":"E Gez","year":"2013","unstructured":"Gez\u00a0E et\u00a0al (2013) Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: A prospective multi-center study. Radiat Oncol 8:1\u20137","journal-title":"Radiat. Oncol"},{"key":"2545_CR34","doi-asserted-by":"crossref","unstructured":"Alongi, F. et\u00a0al. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: Dosimetric analysis and preliminary patient-reported outcomes. Br. J. Radiol. 94, (2021).","DOI":"10.1259\/bjr.20200848"},{"key":"2545_CR35","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.prro.2021.09.015","volume":"12","author":"RJ Brenneman","year":"2022","unstructured":"Brenneman\u00a0RJ et\u00a0al (2022) Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer. Pract Radiat Oncol 12:e117\u2013e122","journal-title":"Pract Radiat Oncol"},{"key":"2545_CR36","unstructured":"Hannan, R. et\u00a0al. Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer\u2014a Prospective Multi-level MRI-based Dose Escalation Trial. 113, 290\u2013301 (2023)."},{"key":"2545_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/bju.15097","volume":"126","author":"ZA Seymour","year":"2020","unstructured":"Seymour\u00a0ZA et\u00a0al (2020) Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of life. BJU Int 126:367\u2013372","journal-title":"BJU Int"},{"key":"2545_CR38","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00066-019-01477-y","volume":"195","author":"A Sch\u00f6rghofer","year":"2019","unstructured":"Sch\u00f6rghofer\u00a0A et\u00a0al (2019) Risk-adapted moderate hypofractionation of prostate cancer: A prospective analysis of acute toxicity, QOL and outcome in 221 patients. Strahlentherapie und Onkol 195:894\u2013901","journal-title":"Strahlentherapie und Onkol"},{"key":"2545_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-021-01834-1","volume":"16","author":"M Ogita","year":"2021","unstructured":"Ogita\u00a0M et\u00a0al (2021) Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison. Radiat Oncol 16:1\u201311","journal-title":"Radiat. Oncol"},{"key":"2545_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-9-96","volume":"9","author":"M Uhl","year":"2014","unstructured":"Uhl\u00a0M et\u00a0al (2014) Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12\u00a0month toxicity and proctoscopy results of a\u00a0prospective multicenter phase\u00a0II trial. Radiat Oncol 9:1\u20136","journal-title":"Radiat Oncol"},{"key":"2545_CR41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1464-410X.2012.11373.x","volume":"110","author":"G Hatiboglu","year":"2012","unstructured":"Hatiboglu\u00a0G, Pinkawa\u00a0M, Vall\u00e9e\u00a0JP, Hadaschik\u00a0B, Hohenfellner\u00a0M (2012) Application technique: Placement of a prostate - Rectum spacer in men undergoing prostate radiation therapy. BJU Int 110:647\u2013652","journal-title":"BJU Int"},{"key":"2545_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.prro.2016.10.004","volume":"7","author":"BW Fischer-Valuck","year":"2017","unstructured":"Fischer-Valuck\u00a0BW, Chundury\u00a0A, Gay\u00a0H, Bosch\u00a0W, Michalski\u00a0J (2017) Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall. Pract Radiat Oncol 7:195\u2013202","journal-title":"Pract Radiat Oncol"},{"key":"2545_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijrobp.2021.03.025","volume":"111","author":"MR Folkert","year":"2021","unstructured":"Folkert\u00a0MR et\u00a0al (2021) A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer. Int J Radiat Oncol Biol Phys 111:101\u2013109","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR44","doi-asserted-by":"crossref","unstructured":"Hasan, S.\u00a0et\u00a0al. Proton therapy for high-risk prostate cancer Results from the Proton Collaborative Group PCG 001-09 prospective registry trial. Prostate (2023).","DOI":"10.1002\/pros.24525"},{"key":"2545_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijrobp.2016.02.025","volume":"95","author":"G Habl","year":"2016","unstructured":"Habl\u00a0G et\u00a0al (2016) Acute Toxicity and Quality of Life in Patients with Prostate Cancer Treated with Protons or Carbon Ions in a Prospective Randomized Phase II Study - The IPI Trial. Int J Radiat Oncol Biol Phys 95:435\u2013443","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm12121982","volume":"12","author":"F Alongi","year":"2022","unstructured":"Alongi\u00a0F et\u00a0al (2022) 1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients. J\u00a0Pers Med 12:1\u20139","journal-title":"J. Pers. Med"},{"key":"2545_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100755","volume":"6","author":"NB Newman","year":"2021","unstructured":"Newman\u00a0NB, Rajkumar\u00a0A, Cleary\u00a0RK, Shinohara\u00a0ET, Kirschner\u00a0AN (2021) Patient Reported Quality of Life Outcomes After Definitive Radiation Therapy With Absorbable Spacer Hydrogel for Prostate Cancer. Adv Radiat Oncol 6:100755","journal-title":"Adv Radiat Oncol"},{"key":"2545_CR48","doi-asserted-by":"crossref","unstructured":"Eckert, F. et\u00a0al. Prospective evaluation of a\u00a0hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer. BMC Cancer 13, (2013).","DOI":"10.1186\/1471-2407-13-27"},{"key":"2545_CR49","first-page":"121","volume":"27","author":"BGL Vanneste","year":"2021","unstructured":"Vanneste\u00a0BGL et\u00a0al (2021) Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients? Clin Transl Radiat Oncol 27:121\u2013125","journal-title":"Clin. Transl. Radiat. Oncol"},{"key":"2545_CR50","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.21873\/invivo.12637","volume":"35","author":"P Pepe","year":"2021","unstructured":"Pepe\u00a0P, Tamburo\u00a0M, Pennisi\u00a0M, Marletta\u00a0D, Marletta\u00a0F (2021) Clinical outcomes of hydrogel spacer injection space OAR in men submitted to hypofractionated radiotherapy for prostate cancer. In Vivo (Brooklyn) 35:3385\u20133389","journal-title":"In Vivo (Brooklyn)"},{"key":"2545_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-022-02103-5","volume":"17","author":"AW See","year":"2022","unstructured":"See\u00a0AW et\u00a0al (2022) Dose-escalated radiotherapy to 82\u202fGy for prostate cancer following insertion of a\u00a0peri-rectal hydrogel spacer: 3\u2011year outcomes from a\u00a0phase\u00a0II trial. Radiat Oncol 17:1\u201310","journal-title":"Radiat. Oncol"},{"key":"2545_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.701998","volume":"11","author":"I Latorzeff","year":"2021","unstructured":"Latorzeff\u00a0I et\u00a0al (2021) Use of a\u00a0Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study. Front Oncol 11:1\u201310","journal-title":"Front. Oncol"},{"key":"2545_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00345-024-04784-x","volume":"42","author":"DMC Poon","year":"2024","unstructured":"Poon\u00a0DMC et\u00a0al (2024) One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer. World J Urol 42:1\u20139","journal-title":"World J. Urol"},{"key":"2545_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1259\/bjr.20210521","volume":"94","author":"R MAZZOLA","year":"2021","unstructured":"MAZZOLA\u00a0R et\u00a0al (2021) Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T\u2011MRI- guided adaptive stereotactic body radiotherapy for localized prostate cancer. Br J Radiol 94:1\u20136","journal-title":"Br. J. Radiol"},{"key":"2545_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.urology.2017.11.016","volume":"115","author":"LI Karsh","year":"2018","unstructured":"Karsh\u00a0LI et\u00a0al (2018) Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data. Urology 115:39\u201344","journal-title":"Urology"},{"key":"2545_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-019-1248-6","volume":"14","author":"A Sch\u00f6rghofer","year":"2019","unstructured":"Sch\u00f6rghofer\u00a0A et\u00a0al (2019) Rectum-spacer related acute toxicity - Endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers. Radiat Oncol 14:1\u20137","journal-title":"Radiat. Oncol"},{"key":"2545_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.radonc.2015.07.027","volume":"116","author":"F Wolf","year":"2015","unstructured":"Wolf\u00a0F et\u00a0al (2015) Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency. Radiother Oncol 116:221\u2013225","journal-title":"Radiother Oncol"},{"key":"2545_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2025.03.009","author":"J Lippens","year":"2025","unstructured":"Lippens\u00a0J et\u00a0al (2025) Implantable Rectal Spacers in Prostate Cancer Radiation Therapy: A Systematic Review. Pract Radiat Oncol. https:\/\/doi.org\/10.1016\/j.prro.2025.03.009","journal-title":"Pract Radiat Oncol"},{"key":"2545_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5114\/wo.2025.148388","volume":"29","author":"M Miszczyk","year":"2025","unstructured":"Miszczyk\u00a0M et\u00a0al (2025) Perirectal spacers in radiotherapy for prostate cancer \u2013 a systematic review and meta-analysis. Wsp\u00f3\u0142czesna Onkol 29:36\u201344","journal-title":"Wsp\u00f3\u0142czesna Onkol"},{"key":"2545_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00066-016-1040-6","volume":"193","author":"M Pinkawa","year":"2017","unstructured":"Pinkawa\u00a0M et\u00a0al (2017) Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer. Strahlentherapie und Onkol 193:22\u201328","journal-title":"Strahlentherapie und Onkol"},{"key":"2545_CR61","doi-asserted-by":"crossref","unstructured":"Cloitre, M. et\u00a0al. Toxicity, quality of life, and PSA control after 50\u202fGy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a\u00a0rectal spacer: results of a\u00a0phase\u00a0I\/II study. Br. J. Radiol. 96, (2023).","DOI":"10.1259\/bjr.20220803"},{"key":"2545_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijrobp.2021.03.027","volume":"111","author":"A Magli","year":"2021","unstructured":"Magli\u00a0A et\u00a0al (2021) Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 111:93\u2013100","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR63","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1016\/j.prro.2023.11.010","volume":"14","author":"MT King","year":"2024","unstructured":"King\u00a0MT et\u00a0al (2024) Evaluating the Quality-of-Life Effect of Apical Spacing with Hyaluronic Acid Prior to Hypofractionated Prostate Radiation Therapy: A Secondary Analysis. Pract Radiat Oncol 14:e214\u2013e219","journal-title":"Pract Radiat Oncol"},{"key":"2545_CR64","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bju.14192","volume":"122","author":"M Chao","year":"2018","unstructured":"Chao\u00a0M et\u00a0al (2018) Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy. BJU Int 122:427\u2013433","journal-title":"BJU Int"},{"key":"2545_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijrobp.2012.12.019","volume":"87","author":"DY Song","year":"2013","unstructured":"Song\u00a0DY et\u00a0al (2013) A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: Analysis of dosimetric outcomes. Int J Radiat Oncol Biol Phys 87:81\u201387","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2024.101624","volume":"9","author":"CE Grossman","year":"2024","unstructured":"Grossman\u00a0CE, Akin\u00a0O, Damato\u00a0AL, Nunez\u00a0DA, Zelefsky\u00a0MJ (2024) Depth of Hydrogel Spacer Rectal Wall Infiltration Was Not Associated With Rectal Toxicity: Results From a Randomized Prospective Trial. Adv Radiat Oncol 9:101624","journal-title":"Adv. Radiat. Oncol"},{"key":"2545_CR67","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1002\/mp.17292","volume":"51","author":"M Svatos","year":"2024","unstructured":"Svatos\u00a0M et\u00a0al (2024) Symmetry, separation, and stability: Physical properties for effective dosimetric space with a stabilized hyaluronic acid spacer. Med Phys 51:6231\u20136245","journal-title":"Med Phys"},{"key":"2545_CR68","doi-asserted-by":"publisher","DOI":"10.1200\/cci-24-00252","author":"KD Shah","year":"2025","unstructured":"Shah\u00a0KD et\u00a0al (2025) Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy. JCO Clin Cancer Informatics. https:\/\/doi.org\/10.1200\/cci-24-00252","journal-title":"JCO Clin. Cancer Informatics"},{"key":"2545_CR69","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00345-018-2502-5","volume":"37","author":"M Chao","year":"2019","unstructured":"Chao\u00a0M et\u00a0al (2019) The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial. World J Urol 37:1111\u20131116","journal-title":"World J. Urol"},{"key":"2545_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-025-00961-0","author":"CHM Wong","year":"2025","unstructured":"Wong\u00a0CHM et\u00a0al (2025) Does biodegradable peri-rectal spacer mitigate treatment toxicities in radiation therapy for localised prostate cancer\u2014a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. https:\/\/doi.org\/10.1038\/s41391-025-00961-0","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2545_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-020-01534-2","volume":"15","author":"O Jmour","year":"2020","unstructured":"Jmour\u00a0O et\u00a0al (2020) CBCT evaluation of inter- And intra-fraction motions during prostate stereotactic body radiotherapy: A\u00a0technical note. Radiat Oncol 15:1\u20136","journal-title":"Radiat. Oncol"},{"key":"2545_CR72","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urpr.2015.04.002","volume":"3","author":"CM Pieczonka","year":"2016","unstructured":"Pieczonka\u00a0CM et\u00a0al (2016) Hydrogel Spacer Application Technique, Patient Tolerance and Impact on Prostate Intensity Modulated Radiation Therapy: Results from a Prospective, Multicenter, Pivotal Randomized Controlled Trial. Urol Pract 3:141\u2013146","journal-title":"Urol. Pract"},{"key":"2545_CR73","first-page":"1","volume":"12","author":"L Chen","year":"2022","unstructured":"Chen\u00a0L et\u00a0al (2022) Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer. Front Oncol 12:1\u201310","journal-title":"Front Oncol"},{"key":"2545_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.prro.2023.05.013","volume":"14","author":"M Pinkawa","year":"2024","unstructured":"Pinkawa\u00a0M et\u00a0al (2024) Application of a\u00a0Radiopaque Viscous Hydrogel Spacer for Prostate Cancer Radiation Therapy: A\u00a0Prospective Phase\u00a02\u00a0Study. Pract Radiat Oncol 14:57\u201364","journal-title":"Pract. Radiat. Oncol"},{"key":"2545_CR75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrurol.2013.96","volume":"10","author":"R Valdagni","year":"2013","unstructured":"Valdagni\u00a0R, Rancati\u00a0T (2013) Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol 10:345\u2013357","journal-title":"Nat Rev Urol"},{"key":"2545_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.meddos.2017.07.002","volume":"42","author":"RT Jones","year":"2017","unstructured":"Jones\u00a0RT et\u00a0al (2017) Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials. Med Dosim 42:341\u2013347","journal-title":"Med Dosim"},{"key":"2545_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00066-020-01633-9","volume":"197","author":"M Afkhami Ardekani","year":"2021","unstructured":"Afkhami Ardekani\u00a0M, Ghaffari\u00a0H, Navaser\u00a0M, Zoljalali Moghaddam\u00a0SH, Refahi\u00a0S (2021) Effectiveness of rectal displacement devices in managing prostate motion: a systematic review. Strahlentherapie und Onkol 197:97\u2013115","journal-title":"Strahlentherapie und Onkol"},{"key":"2545_CR78","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2147\/CMAR.S118781","volume":"9","author":"NA Serrano","year":"2017","unstructured":"Serrano\u00a0NA, Kalman\u00a0NS, Anscher\u00a0MS (2017) Reducing rectal injury in men receiving prostate cancer radiation therapy: Current perspectives. Cancer Manag Res 9:339\u2013350","journal-title":"Cancer Manag. Res"},{"key":"2545_CR79","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/curroncol30010058","volume":"30","author":"D Ahmad Khalil","year":"2023","unstructured":"Ahmad Khalil\u00a0D et\u00a0al (2023) Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study. Curr Oncol 30:758\u2013768","journal-title":"Curr. Oncol"},{"key":"2545_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-022-02025-2","volume":"17","author":"D Ahmad Khalil","year":"2022","unstructured":"Ahmad Khalil\u00a0D et\u00a0al (2022) Dosimetric feasibility of moderately hypofractionated\/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer. Radiat Oncol 17:1\u201312","journal-title":"Radiat Oncol"},{"key":"2545_CR81","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","volume":"97","author":"DA Hamstra","year":"2017","unstructured":"Hamstra\u00a0DA et\u00a0al (2017) Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Int J Radiat Oncol Biol Phys 97:976\u2013985","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR82","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.prro.2017.07.008","volume":"8","author":"DA Hamstra","year":"2018","unstructured":"Hamstra\u00a0DA et\u00a0al (2018) Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal\/prostate spacer: Secondary analysis of a phase 3 trial. Pract Radiat Oncol 8:e7\u2013e15","journal-title":"Pract Radiat Oncol"},{"key":"2545_CR83","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.urology.2023.12.034","volume":"188","author":"JC Millot","year":"2024","unstructured":"Millot\u00a0JC et\u00a0al (2024) Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy. Urology 188:94\u2013100","journal-title":"Urology"},{"key":"2545_CR84","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ijrobp.2017.07.044","volume":"99","author":"RC Wortel","year":"2017","unstructured":"Wortel\u00a0RC et\u00a0al (2017) Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels. Int J Radiat Oncol Biol Phys 99:1243\u20131252","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/acm2.12051","volume":"18","author":"SG Hedrick","year":"2017","unstructured":"Hedrick\u00a0SG et\u00a0al (2017) A comparison between hydrogel spacer and endorectal balloon: An analysis of intrafraction prostate motion during proton therapy. J\u00a0Appl Clin Med Phys 18:106\u2013112","journal-title":"J. Appl. Clin. Med. Phys"},{"key":"2545_CR86","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ijrobp.2020.01.026","volume":"108","author":"TKT Dinh","year":"2020","unstructured":"Dinh\u00a0TKT et\u00a0al (2020) Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study. Int J Radiat Oncol Biol Phys 108:635\u2013643","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"2545_CR87","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejmp.2020.11.033","volume":"81","author":"Z Su","year":"2021","unstructured":"Su\u00a0Z et\u00a0al (2021) A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapy. Phys Medica 81:47\u201351","journal-title":"Phys Medica"},{"key":"2545_CR88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.radonc.2019.08.027","volume":"141","author":"P Ghadjar","year":"2019","unstructured":"Ghadjar\u00a0P et\u00a0al (2019) ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiother Oncol 141:5\u201313","journal-title":"Radiother. Oncol"},{"key":"2545_CR89","unstructured":"NICE guideline [NG131] (2019) Overview | Prostate cancer: diagnosis and management | Guidance | NICE. Nice 6."},{"key":"2545_CR90","doi-asserted-by":"crossref","unstructured":"Eastham, J. A. et\u00a0al. Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline 2022Endorsed by SUO. (2022).","DOI":"10.1097\/JU.0000000000002854"},{"key":"2545_CR91","volume-title":"EAU - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer","author":"N Mottet","year":"2021","unstructured":"Mottet\u00a0N, Cornford\u00a0P, Briers\u00a0E, De Santis\u00a0M, Fanti\u00a0S (2021) EAU - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer"},{"key":"2545_CR92","unstructured":"Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.\u202fV. (AWMF) (2024) S3-Leitlinie Prostatakarzinom Leitlinie (Langversion)."},{"key":"2545_CR93","unstructured":"NICE (2023) Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer. Natl. Inst. Heal. Care Excell. 1\u20138."},{"key":"2545_CR94","unstructured":"Porkhun, K. & Hagen, G.\u00a0Hydrogel rectal spacer SpaceOARTM in prostate cancer radiation therapy - Health technology assessment. Norwegian Institute of Public Health Division for Health Services (2021)."},{"key":"2545_CR95","unstructured":"NICE (2022) Interventional procedure overview of biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer."},{"key":"2545_CR96","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1016\/j.prro.2018.10.003","volume":"9","author":"JF Levy","year":"2019","unstructured":"Levy\u00a0JF et\u00a0al (2019) Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy. Pract Radiat Oncol 9:e172\u2013e179","journal-title":"Pract Radiat Oncol"},{"key":"2545_CR97","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","volume":"391","author":"N van As","year":"2024","unstructured":"van As\u00a0N et\u00a0al (2024) Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer. N Engl J Med 391:1413\u20131425","journal-title":"N. Engl. J. Med"},{"key":"2545_CR98","first-page":"1","volume":"11","author":"M Moll","year":"2023","unstructured":"Moll\u00a0M, Goldner\u00a0G (2023) Comparison of treatment costs for primary localized prostate cancer in Austria and Vienna: an economic analysis. Front Public Heal 11:1\u20137","journal-title":"Front. Public Heal"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02545-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:01:50Z","timestamp":1784710910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02545-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02545-w","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, the affiliations were all shifted by one number because an incorrect affiliation was accidentally inserted as number 2. The previous affiliation 2 was removed, and the affiliations were reassigned correctly. In addition, the previous affiliation 7 had been incorrectly assigned to all authors; this was also corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Moll, N.P.\u00a0Mendenhall, G.\u00a0Goldner, M.\u00a0Miszczyk, S.\u00a0Sushant, C.\u00a0L\u00fctgendorf-Caucig, E.\u00a0Hug and W.M.\u00a0Mendenhall declare that they have no competing interests. M.\u00a0Moll received honoraria from AstraZeneca, unrelated to this project. G.\u00a0Goldner received honoraria from BSM Diagnostica; Jansen Cillag, Astellas, Heinrich PR, unrelated to this project. M.\u00a0Miszczyk was supported by the European Urological Scholarship Programme (EUSP) Scholarship of the European Association of Urology (EAU).","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}